Form EFFECT Artiva Biotherapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 14, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- World Pool Association Celebrates Potts and Fisher's Triumph at the 2026 WPA Heyball World Championships
- Deployable Energy and Hornbeck Offshore Partner to Advance Maritime Nuclear Power
- Curative and Vytalize Health Finalize Network Agreement, Expanding Hassle-Free, $0-Copay Healthcare Access in the Northeast
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share